4//SEC Filing
Gerard Christopher 4
Accession 0000896262-21-000072
CIK 0000896262other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:30 PM ET
Size
9.6 KB
Accession
0000896262-21-000072
Insider Transaction Report
Form 4
AMEDISYS INCAMED
Gerard Christopher
Chief Operating Officer
Transactions
- Sale
Common Stock
2021-05-25$260.78/sh−100$26,078→ 41,606 total - Sale
Common Stock
2021-05-25$257.35/sh−100$25,735→ 42,756 total - Sale
Common Stock
2021-05-25$259.69/sh−1,050$272,675→ 41,706 total
Holdings
- 279(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]These sales were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.35 to $257.36, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.32 to $260.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
- [F4]The information in this report is based on a plan statement dated as of March 31, 2021.
Documents
Issuer
AMEDISYS INC
CIK 0000896262
Entity typeother
Related Parties
1- filerCIK 0001694097
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 4:30 PM ET
- Size
- 9.6 KB